10 transactions in one company, from January 30, 2026 to August 6, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | AKBA | 10 | $87K | $474K |
10 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEODERIV | Aug 6 | M | 350,000 | $0.00 | —? |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Aug 6 | M | 350,000 | $0.63 | $221K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Mar 4 | P | 69,270 | $1.25 | $87K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Feb 2 | SPLAN | 83,689 | $1.39 | $116K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Feb 2 | APLAN | 175,250 | $1.41 | $247K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Feb 2 | SPLAN | 114,891 | $1.39 | $160K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Feb 2 | SPLAN | 96,065 | $1.39 | $134K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Feb 2 | SPLAN | 46,660 | $1.39 | $65K |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEODERIV | Jan 30 | A | 1,115,000 | $0.00 | —? |
| Akebia Therapeutics, Inc. | AKBA | John P. ButlerCEO | Jan 30 | A | 743,000 | $0.00 | — |